Guardant
Healthcare Services · California, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
3100 Hanover St, Palo Alto, California, ...Phone Number
(855) 698-8887Website
www.guardanthealth.comRevenue
$1.1 BillionStock Symbol
GHIndustry
ZI Rank: 17
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
18
28
22
20
17
17
About Guardant
Guardant Health, which was founded in 2012 is headquartered in Palo Alto California. The company offers classifications and rare-cell diagnostics services focused on cancer. Guardant Health also provides testing reports which allows physicians to identify treatment alternatives for cancer patients.Explore more
Guardant Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Guardant your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Guardant has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Guardant recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Guardant
Product Launch: Get notified when Guardant launches new products
Check out if Guardant is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Guardant had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Guardant has new funding data
Guardant, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Guardant
Find 3 more new buyers
Compare Similar Companies to Guardant
Compare insights from companies similar to Guardant, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Guardant is experiencing low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Guardant is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Guardant.
Guardant financials insights
Gather financial insights about Guardant, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series A
$10M
Series B
$30M
2015
Series C
$50M
2016
Series D
$100M
2017
Series E
$360M
2018
Stock Offering
$273.1M
2019
Stock Offering
$319.5M
2025
Share Placement
$100M
Guardant Tech Stack
A closer look at the technologies used by Guardant
See more technologies
Most Recent Scoops
Pain Point
Pain Point, Spending/Investment, Intellectual Property, Lawsuits, Legal Affairs
Open Position
Project
Guardant has completed patient enrollment in its clinical trial for Shield lung cancer screening FDA approval, with clinical follow-up ongoing and the clinical database lock expected before year-end or in early next year, building on the product's existing breakthrough device designation for a 10-cancer panel.
Medical Research, Clinical Operations
Project
Guardant has announced that UnitedHealth Group, the largest commercial insurer in the United States, will begin covering Shield for colorectal cancer screening in adults aged 45 and older as a primary screening option for average-risk adults, effective August 1.
Project
Guardant News & Media
Guardant Health, Inc. (GH) Q2 2026 Earnings Call Transcript
Guardant Health, Inc. (GH) Q2 2026 Earnings Call July 30, 2026 4:30 PM EDTCompany ParticipantsZarak Khurshid - Vice President of Investor RelationsHelmy...Strong Results Boosted Guardant Health (GH) in Q2
Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” second-quarter 2026 investor letter. A copy of the letter can be downloaded here. U.S. equities experienced a strong recovery in Q2 2026, with the S&P 500 Index gaining 15.2%, marking its best quarter since 2020. A ceasefire between the United States […]Guardant Health stock surges on colon cancer blood test news
Guardant Health (GH) investors have a new number to think about this week. Bernstein SocGen Group raised its price target on the cancer-screening company's stock to $200 a share, up from $175. Bernstein also kept its Outperform rating intact. The new price target came less than a day after a ...Why Are Guardant Health (GH) Shares Soaring Today
Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 5.4% in the afternoon session after several investment firms issued positive ratings, citing the recent FDA approval for the company's G360 assay.
Read more news
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Guardant
Sign Up For FreeTo access detailed company insights
Guardant Health, which was founded in 2012 is headquartered in Palo Alto California. The company offers classifications and rare-cell diagnostics services focused on cancer. Guardant Health also provides testing reports which allows physicians to identify treatment alternatives for cancer patients.... Read More
